Tag Archive for Financial Reports

Hot Business News Today

Herbalife Reports Q4 and Full-Year Sales Growth

by  •  • 0 Comments

Herbalife Delivers Fourth Quarter and Full-Year Net Sales Growth, Net Sales and Adjusted EBITDA¹ Exceed Guidance.
Los Angeles, CA – Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, reported financial results for the fourth quarter and year ended December 31, 2025.

“We exited 2025 with solid momentum, delivering Q4 and full‑year net sales growth and adjusted EBITDA1 above guidance. Cristiano Ronaldo’s investment in Pro2col reflects our shared ambition to scale personalized nutrition and wellness globally—uniting science, data, AI, innovation, and community to improve the health and performance of millions.”

– Stephan Gratziani, CEO
Highlights
Fourth Quarter 2025

Net sales up 6.3% vs. Q4 ‘24 to $1.3 billion; exceeds guidance

Up 5.5% year-over-year on constant currency basis2; exceeds guidance

Net income attributable to Herbalife of $85.4 million; adjusted net income1 of $47.5 million
Adjusted EBITDA1 of $156.1 million, or $167.7 million on a constant currency basis2; both exceed guidance
Diluted EPS of $0.81; adjusted diluted EPS1 of $0.45

Full-Year 2025

Net sales up 0.9% vs. 2024 to $5.0 billion; exceeds guidance

Includes 160 basis points of foreign currency (“FX”) headwind
Up 2.5% year-over-year on constant currency basis2, exceeds guidance

Net income attributable to Herbalife of $228.3 million; adjusted net income1 of $219.4 million
Adjusted EBITDA1 of $657.6 million, or $713.9 million on a constant currency basis2; both exceed guidance

Credit Agreement EBITDA1 of

Read more...

Hot Business News Today

Medifast Announces Fourth Quarter and Full Year 2025 Financial Results

by  •  • 0 Comments

Baltimore, MD – Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the fourth quarter and full year ended December 31, 2025.
Fourth Quarter 2025

Revenue of $75.1 million, with revenue per active earning coach of $4,664
Independent active earning coaches of 16,100
Net loss of $18.1 million, or $1.65 per diluted share (“EPS”), which includes the tax provision charge to establish a non-cash valuation allowance on the Company’s deferred tax balance of $12.1 million (or $1.10 per diluted share)
Cash, cash equivalents, and investment Securities of $167.3 million and no debt

Full Year 2025

Revenue of $385.8 million
Net loss of $18.7 million, or $1.70 per diluted share, which includes the tax provision charge to establish a non-cash valuation allowance on the Company’s deferred tax balance of $12.1 million (or $1.10 per diluted share)

“As we enter 2026, Medifast is moving from defining its business transformation strategy to executing on a new path to growth, leading to profitability as we become wholly focused on optimal metabolic health,”

said Dan Chard, Chairman and Chief Executive Officer of Medifast.

“In the fourth quarter, we saw coach productivity turn positive year-over-year for the first time since 2022, which has historically been a lead indicator of

Read more...

Hot Business News Today

USANA Reports Q4 and Full Year 2025 Results

by  •  • 0 Comments

USANA Health Sciences Reports Fourth Quarter and Full Year 2025 Results and Provides Fiscal Year 2026 Outlook.
Salt Lake City, Utah – USANA Health Sciences, Inc. (NYSE: USNA), a global leader in direct selling, today announced financial results for its fiscal fourth quarter and fiscal year ended January 3, 2026.

“USANA delivered fourth quarter net sales in line with our preliminary results announced on January 12, 2026,”

said Kevin Guest, Chairman and Chief Executive Officer.

“We began to see signs of stabilization in active customer counts in our core nutritional business as net sales in this segment increased modestly sequentially, led by growth in key markets including mainland China, the United States and Canada. Meanwhile, our omnichannel brands, Hiya and Rise, posted solid year-over-year growth.”

Key Financial and Operating Results

Q4 2025

Q4 2024

FY 2025

FY 2024

Net sales

$226.2

$213.6

$925.3

$854.5

Net (loss) earnings*

$-1.8

$4.5

$10.8

$42.0

Diluted EPS

$-0.10

$0.23

$0.58

$2.19

Adjusted diluted EPS(1)

$0.60

$0.64

$1.93

$2.59

Adjusted EBITDA(2)

$27.3

$25.5

$101.3

$110.3

USANA Active Customers

387,000

454,000

387,000

454,000

Hiya Active Monthly Subscribers

181,700

N/A

181,700

N/A

*Pretax earnings for Q4 2025 totaled $4.0 million with income tax expense of $5.8 million. The adjustment to income taxes during the period, largely as a result of one-time impairment and cost realignment charges, is about $3.1 million greater than what would have been expected using the previously expected 65% tax rate.

Net sales, Net (loss) earnings and Adjusted EBITDA figures

Read more...

Hot Business News Today

Natural Health Trends Reports Fourth Quarter and Full Year 2025 Financial Results

by  •  • 0 Comments

– Net sales decreased 10% year over year, but increased 3% sequentially
– Restructuring initiatives to achieve $1.5 million annualized savings substantially complete
– Declared a quarterly cash dividend of $0.10 per share
Los Angeles, CA – Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the fourth quarter and full year ended December 31, 2025.
Fourth Quarter 2025 Financial Highlights

•
Revenue of $9.7 million increased 3% compared to $9.5 million in the third quarter of 2025 and declined 10% compared to $10.8 million in the fourth quarter of 2024.

•
Operating loss was $635,000 compared to $495,000 and $421,000 in the third quarter of 2025 and fourth quarter of 2024, respectively. Excluding restructuring-related charges of $283,000 recognized during the fourth quarter, operating loss would have been $352,000 during the quarter.

•
Net loss was $588,000, or $0.05 per diluted share, compared to net loss of $431,000, or $0.04 per diluted share, and net income of $176,000, or $0.02 per diluted share, in the third quarter of 2025 and fourth quarter of 2024, respectively. Despite the loss before income taxes, tax expense of $175,000 was recognized in the fourth quarter due to an

Read more...

Hot Business News Today

Nu Skin Enterprises Reports Fourth Quarter and Full-Year 2025 Results Within Guidance

by  •  • 0 Comments

Company provides initial outlook for Q1 and fiscal year 2026, forecasting a return to revenue growth by year’s end. 
Provo, Utah — Nu Skin Enterprises Inc. (NYSE: NUS) announced fourth quarter and full-year 2025 revenue and earnings within guidance with more than 50% growth in earnings for 2025.

“We are pleased to achieve fourth quarter results within our guidance range for both revenue and earnings per share,”

said Ryan Napierski, Nu Skin president and CEO.

“This past year was a pivotal year as we furthered our transformation toward becoming the world’s leading intelligent beauty and wellness platform and laid the groundwork for our 2026 growth initiatives. Looking ahead, we continue to build sales leader alignment in the first half of the year around the global launch of Prysm iO, positioning us for a return to year-over-year revenue growth by year’s end.
“We are now placing Prysm iO intelligent wellness devices into the hands of sales leaders around the world ahead of our consumer launch in the second half of the year. More than 20,000 devices are already in the hands of our sales leaders generating more than 700,000 scans. As we gain greater adoption and more individuals are scanning and receiving their personalized product recommendations,

Read more...

Hot Business News Today

Coway Announces Financial Results for Q4 and FY2025

by  •  • 0 Comments

Seoul, South Korea – Coway Co., Ltd., the “Best Life Solution Company,” has today announced its financial results for the fourth quarter and fiscal year 2025.

“In the face of persistent global economic uncertainties, Coway was able to realize both top-line growth and profitability in 2025 by focusing on our fundamentals, strengthening our R&D capabilities and diversifying our product portfolio,”

stated Jangwon Seo, CEO of Coway.

“Going forward, we will continue to maintain this stable momentum through product innovation across both our domestic and global markets.”

Coway’s reported earnings are as follows:

Fourth-quarter revenue: KRW 1,275.4 billion (+13.3% YoY)
Fourth-quarter operating profit: KRW 181.6 billion (-1.0% YoY)
Annual revenue: KRW 4,963.6 billion (+15.2% YoY)
Annual operating profit: KRW 878.7 billion (+10.5% YoY)

*The reported figures are taken from the consolidated K-IFRS (International Financial Reporting Standards) statement.
The company’s strong results across both domestic and global markets in 2025 were driven in no small part by the visionary mid- to long-term strategy previously introduced by Junhyuk Bang, Chairman of Netmarble and Coway, which includes launching innovative products, expanding into new business areas and strengthening the company’s global footprint.
Coway’s domestic business reported an annual revenue of KRW 2,865.6 billion in 2025, marking an 11.0% year-over-year increase. This performance was bolstered, in

Read more...

Hot Business News Today

Zinzino Publishes Preliminary January 2026 Sales Report

by  •  • 0 Comments

Zinzino group revenue increased with a total of 20%, compared with the previous year.
Gothenburg, Sweden – Zinzino AB (publ) (ZZ-B.ST), a leading global direct selling company, reports that the revenue in January for Zinzino’s sales markets increased by 20% and amounted to SEK 274.1 (229.2) million.
Faun Pharma’s external sales increased and amounted to SEK 7.1 (4.7) million.
Overall, the Group increased revenues by 20% to SEK 281.2 (233.9) million compared with the previous year.
Revenues were distributed as follows:

Regions, mSEK
26-Jan
25-Jan
Change

The Nordics
27.3
25.9
5%

Central Europe
90.1
69.4
30%

East Europe
29.4
34.2
-14%

South & West Europe
46.6
44.1
6%

The Baltics
10.5
10.4
1%

North America
41.3
21.3
94%

South America
4.0
0.9
344%

Asia-Pacific
23.0
21.5
7%

Africa
1.9
1.5
27%

Zinzino
274.1
229.2
20%

Faun Pharma
7.1
4.7
51%

Zinzino Group
281.2
233.9
20%

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA, Mexico
South America: Peru, Colombia
Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea
Africa: South Africa

About Zinzino
Zinzino AB (publ) (ZZ-B.ST) is a global direct-sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market.
Zinzino’s scientifically proven nutritional supplements are available in more than

Read more...

Hot Business News Today

LR Health & Beauty SE Reports FY2025 Results, Plans Bond Restructuring

by  •  • 0 Comments

LR Health & Beauty SE: Preliminary Results For Financial Year 2025, Target Equity Contribution, and Targeted Restructuring of the 2024/2028 Bonds. 
Ahlen, Germany – Based on the preliminary financial results for the financial year 2025, the Management Board of LR Health & Beauty SE (the “Company”) now expects an EBITDA* reported of around EUR 16 million for the financial year 2025 (previously expected to be between EUR 17.0 million and EUR 20.0 million). At the same time, the Management Board of the Company expects sales (revenue from goods sold) of around EUR 277 million for the full year 2025 (previously expected to be between EUR 276 million and EUR 281 million).
Also today, EY-Parthenon announced the completion of a draft IDW S 6 restructuring opinion in respect of the Company. Pursuant to the analysis set out in that draft restructuring opinion, the Company will for the financial year 2028 achieve an EBITDA* of EUR 27.3 million and sales of EUR 281.5 million in the sensitivity case, and an EBITDA* of EUR 31.4 million as well as sales of EUR 284.7 million in the management case.

Against this background, the Company decided today to enter into discussions with its shareholder and with the bondholders of the

Read more...

Hot Business News Today

Zinzino Announces Merger of It Works! For Increased Distribution Power in North America and Europe

by  •  • 0 Comments

Zinzino announces merger of It Works! into the Zinzino family of businesses for increased distribution power in North America and Europe
Zinzino (publ) (ZZ-B.ST) has today entered into an agreement, and simultaneously closed, to combine with the US-based direct sales company It Works! In an all-share transaction. Through the merger, Zinzino acquired the operational assets of It Works!’ US business, including inventory, distributor agreements, customer agreements, and IP rights, as well as 100% of the shares in It Works! Marketing International UC, an Irish unlimited company, and its wholly owned subsidiaries.
The fixed purchase price amounts to USD 30 million (the “Purchase Price”) which has been paid by Zinzino through a directed set-off issue of 1,843,840 B-shares in Zinzino (the “Directed Issue”). The Directed Issue has been resolved upon by the board of directors of Zinzino, based on the authorization of the Annual General Meeting. The subscription price in the Directed Issue amounts to SEK 145.62 per B-share, which corresponds to the volume weighted average price of Zinzino’s B-share two business days prior to the signing and closing of the transaction. In addition, an additional purchase price estimated to USD 4 million could be paid to It Works! during a five-year span

Read more...

Hot Business News Today

USANA Health Sciences Provides Preliminary Fiscal Year 2025 Net Sales and Issues Initial Fiscal Year 2026 Net Sales Outlook

by  •  • 0 Comments

Salt Lake City, Utah – USANA Health Sciences, Inc. (NYSE: USNA) announced preliminary fiscal year 2025 net sales and initial net sales guidance for fiscal year 2026 ahead of its presentation at the 28th Annual ICR Conference. At the conference, Doug Hekking, CFO, and Walter Noot, COO, will discuss USANA’s strategy, including the Company’s initial fiscal year 2026 sales outlook.
Preliminary Fiscal Year 2025 Net Sales Results
The Company currently anticipates fiscal year 2025 consolidated net sales of approximately $925 million, ahead of its most recently issued guidance of approximately $920 million.
Initial Fiscal Year 2026 Net Sales Outlook
The Company is issuing its initial net sales outlook for fiscal year 2026 in the range of $925 million to $1.0 billion.
The Company’s initial fiscal 2026 net sales outlook reflects:

Net sales from USANA, our core nutritional business, of $720 to $765 million (compared to preliminary net sales for fiscal 2025 of approximately $777 million);
Net sales from Hiya of $140 to $155 million (compared to preliminary net sales for fiscal 2025 of approximately $132 million);
Net sales from Rise Wellness of $65 to $80 million (compared to preliminary net sales for fiscal 2025 of approximately $16 million); and
Fiscal 2026 is a 52-week year, one week less of net

Read more...